B

Bluestar Genomics, Inc - Early Cancer Detection Company Pioneering Epigenomics Platform

46 employees

Bluestar Genomics is a company that delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Biopharma

Date founded

2016

Funding rounds raised

Total raised

$70M

from 1 investors over 1 rounds

B

Bluestar Genomics, Inc - Early Cancer Detection Company Pioneering Epigenomics Platform raised $70M on May 12, 2021

Investors: Pathology Asia

FAQ